ITP Drug Shows Benefit in Hospitalized COVID Patients
Fostamatinib reduced time on supplemental oxygen, improved clinical status
Source: medpagetoday.com
Stay updated with breaking news from Deepa Gotur. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Fostamatinib reduced time on supplemental oxygen, improved clinical status
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct. 11, 2023 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. today announced an upcoming oral presentation highlighting...
/PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization...